‍

Blake, Wm. The First Book of Urizen, object 25. 1794.

‍

Clinical trials have begun for the first anti-aging pill for dogs, aiming to extend the lives of older canines by at least an extra year. The hope is that if this revolutionary drug succeeds, it could pave the way for lifespan-extending drugs for humans.

The trials will involve 1,000 dogs over ten years old, weighing at least 14 pounds, monitored over four years to assess lifespan and quality of life improvements.

Loyal, the San Francisco startup behind the pill, is seeking FDA approval for a chewable version and an injectable alternative for large dogs, with a target of early 2025 for conditional approval.

Researchers have discovered that dogs experience similar environmental conditions to humans and appear to have similar age-related dynamics with disease risk, allowing them to serve as a model for longevity.